Condition
AML With Gene Mutations clinical trials and research
As of November 12, 2026, Find a Trial lists 2 AML With Gene Mutations clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Australia (1), South Korea (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
Dose escalation and expansion of ZE46-0134 for adults with FLT3‑mutated or spliceosome‑mutated relapsed or refractory acute myeloid leukemia.
This trial tests whether ZE46-0134 is safe and can help adults with relapsed or refractory AML who have FLT3 or spliceosome gene mutations.
-
Combining revumenib with standard chemotherapy and targeted therapy for acute myeloid leukemia
This study is testing a new treatment combining revumenib with standard chemotherapy and another targeted therapy to see if it helps newly diagnosed patients with a specific type of acute myeloid leukemia.
Related topics
Quick answers
How many AML With Gene Mutations clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Australia (1 trial), South Korea (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.